Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Highcroft Capital is a venture capital fund based in Wayzata, Minnesota, focusing on early-stage investments in medical technology (medtech) companies. Founded by a team of physician investors, the firm leverages their medical expertise and industry insights to evaluate potential investments from a user perspective. This unique approach allows them to identify innovative solutions that can significantly impact patient care.
The firm operates with a planned fund size ranging from $3 million to $5 million, targeting game-changing products and technologies that aim to reshape the medical industry. Highcroft Capital is committed to advancing the standard of care and facilitating access to venture capital opportunities in healthcare.
Highcroft Capital concentrates on early-stage medical technology companies, specifically in North America. The firm invests in the pre-seed, seed, and seed-plus stages, with check sizes ranging from $3 million to $5 million. Their investment strategy is centered around identifying innovative products and technologies that have the potential to transform the medical landscape.
The fund's thesis emphasizes advancing the standard of care in healthcare, ensuring that their investments not only yield financial returns but also contribute positively to patient outcomes. Highcroft Capital seeks to partner with visionary founders who are dedicated to developing solutions that address critical healthcare challenges.
Marc Newell, MD - Partner & Treasurer. Dr. Newell brings extensive medical expertise and investment experience to the firm, focusing on evaluating healthcare innovations.
Joshua Buckler, MD - Partner & Corporate Secretary. Dr. Buckler has a strong background in clinical practice and healthcare investments, contributing valuable insights into the medtech sector.
Peter Eckman, MD - Partner & Investor Relations. Dr. Eckman specializes in building relationships with investors and portfolio companies, leveraging his medical background to enhance deal flow.
Brian O'Connell, BSEE/MBA - Managing Partner. O'Connell combines engineering and business expertise, focusing on the operational aspects of portfolio companies.
David Madgett, JD - Partner & General Counsel. Madgett provides legal guidance and support, ensuring compliance and strategic alignment in investments.
To pitch Highcroft Capital, founders should send an email to info@highcroftcapital.com. It is recommended to include a comprehensive pitch deck that outlines the business model, market opportunity, and team qualifications. Response times may vary, so patience is advised after submission.
What are Highcroft Capital's investment criteria?
Highcroft Capital focuses on early-stage medical technology companies in North America. They look for innovative products and technologies that can advance the standard of care in healthcare.
How can I pitch to Highcroft Capital?
Founders can reach out via email at info@highcroftcapital.com. It is advisable to include a detailed pitch deck that outlines the business model, market opportunity, and team background.
What makes Highcroft Capital different from other investors?
The firm is led by physician investors who bring unique insights into the medtech industry. This medical background allows them to evaluate companies from a user perspective, enhancing their investment decision-making process.
What is the typical check size for investments?
Highcroft Capital typically invests between $3 million and $5 million in each portfolio company.
What stages does Highcroft Capital invest in?
The firm invests in pre-seed, seed, and seed-plus stages, focusing on early-stage companies that are developing innovative medical technologies.
What kind of support can portfolio companies expect?
Highcroft Capital provides operational support and strategic guidance to its portfolio companies, leveraging the expertise of its physician-led team to help navigate the complexities of the healthcare market.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.